Connaissances Accueil Santé humaine Connaissances All Avis Exposés Science populaire Entretiens Filtrer Therapeutic areas COVID-19 Santé digestive Apply Accueil Santé humaine Connaissances Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Accueil Santé humaine Connaissances Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 Accueil Santé humaine Connaissances Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 Accueil Santé humaine Connaissances RBDCOV Talks HIPRA’s participation: In 5 minutes, what is a recombinant protein vaccine? Accueil Santé humaine Connaissances RBDCOV: The project’s origins and future endeavours Accueil Santé humaine Connaissances Humoral immune response against XBB.1.5 and BQ.1.1 SARS-CoV-2 variants of a fourth dose of PHH-1V vaccine in adult subjects Accueil Santé humaine Connaissances Reactogenicity of third and fourth booster doses of HIPRA PHH-1V, a bivalent recombinant protein vaccine against SARS-CoV-2 Accueil Santé humaine Connaissances Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine in subjects previously vaccinated with a mRNA vaccine Accueil Santé humaine Connaissances One-year humoral response of PHH-1V booster vaccine in subjects previously vaccinated against COVID-19 with a mRNA vaccine Charger plus
